Close

Zogenix (ZGNX) Reports FDA Approval for New Formulation of Zohydro

February 2, 2015 7:02 AM EST Send to a Friend
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login